Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co‐formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomiz...

por Rodbard, H. W., Cariou, B., Pieber, T. R., Endahl, L. A., Zacho, J., Cooper, J. G.
Publicado 2016

Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials

por Leiter, L. A., Müller‐Wieland, D., Baccara‐Dinet, M. T., Letierce, A., Samuel, R., Cariou, B.
Publicado 2017

Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes

por Rodbard, H W, Cariou, B, Zinman, B, Handelsman, Y, Wolden, M L, Rana, A, Mathieu, C
Publicado 2014

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

por Rodbard, H W, Cariou, B, Zinman, B, Handelsman, Y, Philis-Tsimikas, A, Skjøth, T V, Rana, A, Mathieu, C
Publicado 2013

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial (...

por Aroda, V. R., Bailey, T. S., Cariou, B., Kumar, S., Leiter, L. A., Raskin, P., Zacho, J., Andersen, T. H., Philis‐Tsimikas, A.
Publicado 2016

Seipin deficiency alters brown adipose tissue thermogenesis and insulin sensitivity in a non-cell autonomous mode

por Dollet, L., Magré, J., Joubert, M., Le May, C., Ayer, A., Arnaud, L., Pecqueur, C., Blouin, V., Cariou, B., Prieur, X.
Publicado 2016

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

por Yale, J-F, Bakris, G, Cariou, B, Yue, D, David-Neto, E, Xi, L, Figueroa, K, Wajs, E, Usiskin, K, Meininger, G
Publicado 2013

Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms

por Quénéhervé, L., Drui, D., Blin, J., Péré, M., Coron, E., Barbara, G., Barbaro, M. R., Cariou, B., Neunlist, M., Masson, D., Bach-Ngohou, K.
Publicado 2021

French Endocrine Society Guidance on endocrine side effects of immunotherapy

por Castinetti, F, Albarel, F, Archambeaud, F, Bertherat, J, Bouillet, B, Buffier, P, Briet, C, Cariou, B, Caron, Ph, Chabre, O, Chanson, Ph, Cortet, C, Do Cao, C, Drui, D, Haissaguerre, M, Hescot, S, Illouz, F, Kuhn, E, Lahlou, N, Merlen, E, Raverot, V, Smati, S, Verges, B, Borson-Chazot, F
Publicado 2018

Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)

por Mosbah, H., Donadille, B., Vatier, C., Janmaat, S., Atlan, M., Badens, C., Barat, P., Béliard, S., Beltrand, J., Ben Yaou, R., Bismuth, E., Boccara, F., Cariou, B., Chaouat, M., Charriot, G., Christin-Maitre, S., De Kerdanet, M., Delemer, B., Disse, E., Dubois, N., Eymard, B., Fève, B., Lascols, O., Mathurin, P., Nobécourt, E., Poujol-Robert, A., Prevost, G., Richard, P., Sellam, J., Tauveron, I., Treboz, D., Vergès, B., Vermot-Desroches, V., Wahbi, K., Jéru, I., Vantyghem, M. C., Vigouroux, C.
Publicado 2022